We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$79.9B
AUM Growth
+$16.7B
Cap. Flow
+$9.74B
Cap. Flow %
12.19%
Top 10 Hldgs %
13.34%
Holding
4,935
New
829
Increased
1,631
Reduced
1,587
Closed
796

Sector Composition

Rank Sector Weight
1 Healthcare 10.45%
2 Technology 8.65%
3 Financials 8.6%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNOB icon
4226
Center Bancorp
CNOB
$1.62B
-10,964
Closed -$243K
CNQ icon
4227
Canadian Natural Resources
CNQ
$105B
-1,856,352
Closed -$24.2M
CNX icon
4228
CALL
CNX Resources
CNX
$5.4B
-113,300
Closed -$822K
COCP icon
4229
Cocrystal Pharma
COCP
$21.6M
-1,099
Closed -$26K
CODI icon
4230
Compass Diversified
CODI
$865M
-12,965
Closed -$255K
COHU icon
4231
Cohu
COHU
$2.46B
-58,939
Closed -$795K
COLM icon
4232
Columbia Sportswear
COLM
$3.07B
-6,661
Closed -$645K
CPRI icon
4233
CALL
Capri Holdings
CPRI
$1.57B
-25,000
Closed -$829K
CRD.A icon
4234
Crawford & Co Class A
CRD.A
$649M
-18,492
Closed -$201K
CRF
4235
Cornerstone Total Return Fund
CRF
$1.1B
-26,197
Closed -$282K
CRH icon
4236
CRH
CRH
$63.6B
-194,037
Closed -$6.67M
CRL icon
4237
PUT
Charles River Laboratories
CRL
$14B
-20,000
Closed -$2.65M
CRMD icon
4238
CorMedix
CRMD
$645M
-25,319
Closed -$161K
CSQ icon
4239
Calamos Strategic Total Return Fund
CSQ
$3.31B
-19,869
Closed -$252K
CSTL icon
4240
Castle Biosciences
CSTL
$1.03B
-155,538
Closed -$2.81M
CTVA icon
4241
Corteva
CTVA
$54.8B
-949,183
Closed -$26.6M
CUE icon
4242
Cue Biopharma
CUE
$169M
-464
Closed -$117K
CVE icon
4243
PUT
Cenovus Energy
CVE
$59.6B
-200,000
Closed -$1.88M
CVNA icon
4244
Carvana
CVNA
$78.6B
-24,975
Closed -$418K
CXE
4245
DELISTED
MFS High Income Municipal Trust
CXE
-21,952
Closed -$120K
CXW icon
4246
CoreCivic
CXW
$3.35B
-693,367
Closed -$12M
CYD icon
4247
China Yuchai International
CYD
$1.45B
-22,918
Closed -$296K
CYTK icon
4248
CALL
Cytokinetics
CYTK
$10.8B
-250,000
Closed -$2.85M
D icon
4249
PUT
Dominion Energy
D
$58.7B
-201,500
Closed -$16.3M
DAKT icon
4250
Daktronics
DAKT
$918M
-114,566
Closed -$846K

Similar funds

Israel Englander's Q4 2019 Portfolio in Review

As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.

  • Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
  • Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
  • Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
  • Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
  • Israel Englander opened 829 new positions and closed 796 in Q4 2019.
  • Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.